new_0222_0493|RPHM|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0493|RPHM|Long Name|1|1|Reneo Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Reneo Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Reneo Pharmaceuticals Inc Inventories (Quarterly) (USD)|Reneo Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Reneo Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Reneo Pharmaceuticals Inc Book Value (Quarterly) (USD)|Reneo Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Reneo Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Reneo Pharmaceuticals Inc EV to Revenues|Reneo Pharmaceuticals Inc EV to Earnings|Reneo Pharmaceuticals Inc EV to Free Cash Flow|Reneo Pharmaceuticals Inc EV to Assets (Quarterly)|Reneo Pharmaceuticals Inc PS Ratio|Reneo Pharmaceuticals Inc PE Ratio|Reneo Pharmaceuticals Inc Price to Book Value|Reneo Pharmaceuticals Inc PEG Ratio|Reneo Pharmaceuticals Inc Debt to Equity Ratio|Reneo Pharmaceuticals Inc Dividend Yield|Reneo Pharmaceuticals Inc Shareholder Yield (TTM)|Reneo Pharmaceuticals Inc Percent of Shares Outstanding Short|Reneo Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Reneo Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Reneo Pharmaceuticals Inc Return on Invested Capital|Reneo Pharmaceuticals Inc Quality Ratio Score|Reneo Pharmaceuticals Inc Momentum Score|Reneo Pharmaceuticals Inc Beta (1Y)|Reneo Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Reneo Pharmaceuticals Inc Institutional Investor Ownership Percentage|Reneo Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Reneo Pharmaceuticals Inc Total Employees (Annual)|Reneo Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Reneo Pharmaceuticals Inc Shares Outstanding|Reneo Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Reneo Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Reneo Pharmaceuticals Inc Payout Ratio|Reneo Pharmaceuticals Inc Quick Ratio (Quarterly)|Reneo Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Reneo Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Reneo Pharmaceuticals Inc Effective Tax Rate (TTM)|Reneo Pharmaceuticals Inc Return on Equity|Reneo Pharmaceuticals Inc Net Income (TTM) (USD)|Reneo Pharmaceuticals Inc Revenue (TTM) (USD)|Reneo Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Reneo Pharmaceuticals Inc Revenue (Quarterly) (USD)|Reneo Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Reneo Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Reneo Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Reneo Pharmaceuticals Inc Net Income (Quarterly) (USD)|Reneo Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Reneo Pharmaceuticals Inc Price (USD)|Reneo Pharmaceuticals Inc Total Return Price (USD)|Reneo Pharmaceuticals Inc Enterprise Value (USD)|Reneo Pharmaceuticals Inc 30-Day Average Daily Volume|Reneo Pharmaceuticals Inc 1 Year Price Returns (Daily)
new_0222_0493|RPHM|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0493|RPHM||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_0222_0493|RPHM||5|5|91|91|0|91|0|91|91|91|0|91|91|0|0|0|1.43925233645|0|0|0|1.43949044586|0|0|1.43925233645|0|15.3157894737|0|91|91|0|0|0|0|0|30.6666666667|91.3333333333|91|91.3333333333|31.1428571429|0|91|0|0|91.3333333333|91.4|0|0|91|0|0|0|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.43925233645|1.43925233645|1.43925233645|1.44324324324|0
new_0222_0493|RPHM||6|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|214|0|0|0|157|0|0|214|0|19|0|3|3|0|0|0|0|0|9|6|3|6|7|0|3|0|0|6|5|0|0|3|0|0|0|0|6|6|6|6|214|214|214|185|0
new_0222_0493|RPHM||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0493|RPHM|202003|202003|202003||||||||||||||||||||||||||||||||||7.7883||-0.5689||||||-0.5689|||||||||0.924|-4.431|-4.431|0.071|||||
new_0222_0493|RPHM|202006|202006|202006||||||||||||||||||||||||||||||||||7.7883||-0.4734||||||-0.4734|0||||||||0.882|-3.687|-3.687|0.012|||||
new_0222_0493|RPHM|202009|202009|202009||||||||||||||||||||||||||||||||||7.7883||-0.6541||||||-0.6541|0||||||||0.668|-5.094|-5.094|0.005|||||
new_0222_0493|RPHM|202012|202012|202012|55.025|53.613||0.069||97.336|4.58|92.756||-42.115|-44.958|||||||||||||||0.908|0|||||||24.2107|23|-0.2583|||24.2107|||-0.2583||||-19.465|||||1.133|-6.253|-6.253|-0.002|||||
new_0222_0493|RPHM|202103|202103|202103|93.56|91.221||0.081||144.038|3.93|140.108||-48.717|-52.17|||||||||||||||0.556|0|||||||24.2107|29|-0.2979|||24.2107|||-0.2979||||-22.246|||||1.742|-7.212|-7.212|0.002|||||
new_0222_0493|RPHM|202104|202103|202103|||||||||||||||-11.3268|||||||0||1.0356|||||||||25.1632||||24.2107||||||||||||||||||14.4|14.4|257.4131||
new_0222_0493|RPHM|202105|202103|202103|||||||||||||||-6.7261|||||||0||2.8625|||||||||25.0816||||24.2863||||||||||||||||||10.05|10.05|152.8563|73164.0667|
new_0222_0493|RPHM|202106|202106|202106|171.141|167.331||0.085||3.753|3.336|0.417||167.551|-61.386||||-2.0099||||1.3525|||0||4.8179||0.434|0.003||||||95.0652|21.3644|29|-0.43|24.2887||24.2887|||-0.43|-84.639|||-27.775|||||2.949|-9.216|-9.216|0.012|9.33|9.33|59.2826|92288.9|
new_0222_0493|RPHM|202107|202106|202106|||||||||||||||-1.0711||||1.1872|||0||4.7979|||||||||95.8405||||||||||||||||||||||8.19|8.19|31.5935|69341.4667|
new_0222_0493|RPHM|202108|202106|202106|||||||||||||||-3.4864||||1.6124|||0||4.6132|||||||||95.1587||||24.4053||||||||||||||||||11.07|11.07|102.8357|77046.2667|
new_0222_0493|RPHM|202109|202109|202109|162.665|157.734||0.2||6.735|6.353|0.382||156.208|-74.121||||-0.7196||||1.1641|||0||4.7767||1.271|0.003||||||95.4497|24.3968|34|-0.52|24.4077||24.4077|||-0.52|-0.002|||-35.416|||||3.434|-12.735|-12.735|0.017|7.45|7.45|24.1034|122068.7667|
new_0222_0493|RPHM|202110|202109|202109|||||||||||||||-0.0711||||1.025|||0||1.1508|||||||||95.5179||||||||||||||||||||||6.56|6.56|2.3805|28821.9667|
new_0222_0493|RPHM|202111|202109|202109|||||||||||||||-0.3076||||1.0757|||0||1.1374|||||||||95.3211||||24.4239||||||||||||||||||6.88|6.88|10.3024|29907.6|
new_0222_0493|RPHM|202112|202112|202112|||||||||||||||-1.5252||||1.3368|||0||1.019|||||||||95.1114||||||||||||||||||||||8.55|8.55|51.0903|72926.6|
new_0222_0493|RPHM|202201|202112|202112|||||||||||||||0.181||||0.971|||0||0.6973|||||||||83.9172||||||||||||||||||||||6.21|6.21|-6.0616|58587.6333|
new_0222_0493|RPHM|202202|202112|202112|||||||||||||||0.9174||||0.813|||0|||||||||||||||||||||||||||||||||5.2|5.2|-30.7297|45472.4667|